arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

BIOREGENX, INC.

BRGX

— Price unavailable

6 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Neutral

auto_awesome

Analytical Summary

BIOREGENX, INC. shows mixed fundamentals. However, watch Operating Margin (%) and Profit Margin (%) which show concerning trends. Consider comparing against peers in the Technology sector before making investment decisions.

Market Cap —

Dividend Yield —

Revenue Growth -20.8% ↘

Op. Margin -67.1%

ROIC 29.3% ↘

FCF / Share $0.00 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity -0.26

info Valuation on last close.

6-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.85M

↓ -20.8% —

Net Income Profit after all expenses

$-1.54M

↑ +93.3% —

Operating Margin Operating profit as % of sales

-67.1%

↑ +86.4% 4th

FCF / Share Free cash flow per share

$0.00

↑ +105.7% —

Long-Term Debt Long-term obligations

$1.19M

↑ +4.1% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability →

Returns ↓

Financial Health ↑

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Revenue Growth YoY (%)	-20.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-273%)	10420.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+86739%)	-47.2% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-494%)	-78.8% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-756%)	—	—
EPS Growth YoY (%)	100.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	93.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-3936.3% Weak ↓ Weak Declining Year-over-year change in net income	-629.4% Weak Weak Year-over-year change in net income	19.2% Good Good Year-over-year change in net income	—	—
FCF Growth YoY (%)	N/M	-1031.8% Weak ↓ Weak Declining Year-over-year change in free cash flow	79.9% Excellent Excellent Year-over-year change in free cash flow	45.9% Excellent Excellent Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	253.0% Excellent Excellent Compound annual revenue growth over 3 years	127.6% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Operating Margin (%) (%)	-67.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-435%)	—	-493.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2565%)	-185.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1029%)	-83.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-516%)	—
Effective Tax Rate (%) (%)	—	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-83.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-655%)	—	—	-185.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1338%)	-48.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-425%)	—
FCF Margin (%) (%)	1.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-21.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-60.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-153.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-60.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	-0.02x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.02x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.02x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.23x Good Good Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Return on Invested Capital (%)	29.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	802.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	499.1% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	5078.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-142.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-302.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4476.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-346.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-132.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	-129.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	34.0% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+84%)	—	257.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1291%)	38.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+110%)	115.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+522%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Debt to Equity (x)	-0.26x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-158%)	-0.34x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-175%)	-0.90x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-300%)	-0.99x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-321%)	-2.37x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-628%)	—
Interest Coverage (x)	-4.15x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3429.25x Weak Weak Operating income divided by interest expense Optimal: > 5x	-13.25x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$1.19M	$1.08M	$200.00K	$200.00K	$200.00K	—
Debt / EBITDA (x)	-1.01x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.05x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.82x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.55x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.21x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Revenue per Share (USD)	$0.00	$0.00	$0.00	$0.00	$0.00	—
Basic EPS, GAAP (USD)	$0.00	$-0.02	$0.00	$0.00	$0.00	—
Free Cash Flow per Share (USD)	$0.00	$-0.00	$-0.00	$-0.00	$-0.00	—
Book Value per Share (USD)	$-0.00	$-0.00	$-0.00	$-0.00	$-0.00	—
Tangible Book Value per Share (USD)	$-0.00	$-0.00	$-0.00	$-0.00	$-0.00	—
Basic Weighted Avg Shares (shares)	959.71M	939.51M	276.37M	269.75M	269.75M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Working Capital (USD)	$-3.82M	$-3.33M	$-253.61K	$-64.20K	$10.20K	—
LT Debt (USD)	$1.19M	$1.14M	$200.00K	$200.00K	$200.00K	—
Total Equity (USD)	$-4.54M	$-3.38M	$-221.97K	$-201.54K	$-84.23K	$177.64K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Sales/Revenue/Turnover (USD)	$1.85M	$2.34M	$22.24K	$42.16K	$198.58K	—
Depreciation Expense (USD)	$75.08K	—	—	—	—	—
Net Income, GAAP (USD)	$-1.54M	$-23.05M	$-571.17K	$-78.31K	$-96.87K	—
Operating Cash Flow (USD)	$38.97K	$-324.15K	$-13.35K	$-64.65K	$-119.52K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 19 quarters

BIOREGENX, INC.

Analytical Summary

6-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BRGX with peers